Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19 (COVIMMUNITY)
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Terminated
The development and generalisation of vaccination led to a significant drop in the number of patients meeting the inclusion criteria.
Other terminated trials from Centre Hospitalier Universitaire de Saint Etienne
- Healthy · Phase NA · Dec 2025
- Anorexia Nervosa · Phase NA · Jul 2025
- Hemodialysis Patients · Phase PHASE4 · Oct 2024
- Muscle Weakness · Phase NA · Aug 2024
- Muscle Spasticity · Phase NA · Jul 2024
See all terminations from Centre Hospitalier Universitaire de Saint Etienne
Listed as NCT04648709, this observational or N/A phase trial focuses on Covid19 and remains terminated or withdrawn. Sponsored by Centre Hospitalier Universitaire de Saint Etienne, it has been updated 12 times since 2021, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2024 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Mar 2023 — Jan 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Apr 2022 — Mar 2023 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — May 2021 [monthly]
Not Yet Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Saint Etienne
For direct contact, visit the study record on ClinicalTrials.gov .